1. Upponi, S., et al. Pregnancy after breast cancer. European Journal of Cancer (April 2003).
1. Quinn, G. P., et al. Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology 27, no. 35 (December 10, 2009): 5952–57.
2. Woodruff, T. In conversation with author. November 24, 2009.
3. Rueffer, U., et al. Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Annals of Oncology 12, no. 9 (September 2001): 1307–11.
4. Jacobson, R., et al. Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. British Medical Journal 321
(September 30, 2000): 789–92.
5. Oktay, K., et al. Association of BRCA1 mutations with occult primary ovarian insufficiency: A possible explanation for the link between infertility and breast/ovarian cancer risks. Journal of Clinical Oncology 28, no. 2 (January 10, 2010): 240–4.
6. Katz, D., et al. Fertility and pregnancy in patients under age 38 following chemotherapy for breast cancer. Journal of Clinical Oncology 27 (suppl; abstr; 2009): e11541.
7. Simon, B., et al. Preserving fertility after cancer. CA: A Cancer Journal for Clinicians 55 (2005): 211–28.
8. Fertile Hope. Fertility risks. www.fertilehope.org/learn-more/cancer-and-fertility-info/fertility-risks.cfm. (2010); Stearns, V., et al. Breast cancer treatment and ovarian failure: Risk factors and emerging genetic determinants. Nature Reviews: Cancer (November 6, 2006); Drugs@FDA. http://www.accessdata.fda.gov/scripts/cder/drugsatfda (manufacturer information for each drug).
9. Chung, K. In conversation with author. October 7, 2009.
10. Rovó, A., et al. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood 108, no. 3 (August 1, 2006): 1100–1105.
11. Lee, C. In conversation with author. September 30, 2009.
12. Sklar, C. A., et al. Premature menopause in survivors of childhood cancer: A report from the childhood cancer survivor study. Journal of the National Cancer Institute 98, no. 13 (July 5, 2006): 890–96.
13. Haukvik, U. K., et al. Treatment-related premature ovarian failure as a long-term complication after Hodgkin’s lymphoma. Annals of Oncology 17, no. 9 (2006): 1428–33.
1. Foster, R., and Bihrle, R. Current status of retroperitoneal lymph node dissection and testicular cancer: When to operate. Cancer Control 9, no. 4 (2002).
2. Baynosa, J., et al. Timing of breast cancer treatments with oocyte retrieval and embryo cryopreservation. Journal of the American College of Surgeons 209, no. 5 (November 2009): 603–7.
3. Azim, A., Constantini-Ferrando, M., and Oktay, K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. Journal of Clinical Oncology 26, no. 16 (June 1, 2008): 2630–35.
4. Quinn, G. In conversation with author. October 20, 2009.
5. Krotz, S. P., et al. In vitro maturation of oocytes via the pre-fabricated self-assembled artificial human ovary. Journal of Assisted Reproduction and Genetics Epub ahead of print (August 25, 2010).
6. Gerrity, M. B. In conversation with author. November 24, 2009.
7. Dolmans, M. M., et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 116, no. 16 (October 21, 2010): 2908–14.
Epub July 1, 2010.
8. Gonfloni, S., et al. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nature Medicine 15, no. 10 (October 2009): 1179–85. Epub September 27, 2009.
9. Provided courtesy of the Oncofertility Consortium. http://oncofertility.northwestern.edu/health-professionals/fertility-preservation-billing-resources.
1. Therapeutic Sperm Banking. The Center for Reproductive Medicine, The Cleveland Clinic, Cleveland, Ohio. http://www.clevelandclinic.org/reproductiveresearchcenter/
info/patientinfo2.html.
2. Beadle, B. M., et al. The impact of pregnancy on breast cancer outcomes in women ≤ 35 years. Cancer 115 (2009):1174–84.
1. Cost of Adoption Update, 2008-2009. Adoptive Families.
http://www.adoptivefamilies.com/articles.php?aid=2076.
2. Ibid.
1. Oktay, K. In conversation with author. December 15, 2009.
2. Jacobson, H., et al. A proposed unified mechanism for the reduction of human breast cancer risk by the hormones of pregnancy. Cancer Prevention Research 3 (February 2010): 212.
3. Partridge, A. In conversation with author. January 12, 2010.
4. Marsh, K., Ormond, K., and Pergament, E. Cancer, chemotherapy and pregnancy. Newsletter of the Illinois Teratogen Information Service 7, no. 1 (October 1998).
5. Hilakivi-Clarke, L., et al. Maternal exposure to Tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring. Clinical Cancer Research 6, no. 1 (January 2000): 305; Possible Herceptin side effects. Genentech (manufacturer’s labeling). http://www.herceptin.com/adjuvant/breast-cancer-treatment/side-effects.jsp.
6. Serletti, J. Ask-the-Expert Online Conference: Reconstruction Updates. Breastcancer.org. May 2007. http://www.breastcancer.org/treatment/surgery/
reconstruction/ask_expert/2007_05/.
7. Weiss, M. Screening for breast cancer during pregnancy. Breastcancer.org. http://www.breastcancer.org/tips/fert_preg_adopt/
bc_pregnancy/screening.jsp.
8. Romine, L., Mattrey, R., and Brown, M. MR imaging of placenta accreta. Abstract presented to the Radiological Society of North America (RSNA) 95th Annual Meeting, December 2009.
9. Higgins, S., and Haffty, B. G. Pregnancy and lactation after breast-conserving therapy for early stage breast cancer. Cancer 73, no. 8 (April 15, 1994): 2175–80.
10. Stuebe, A., et al. Lactation and incidence of premenopausal breast cancer: A longitudinal study. Archives of Internal Medicine 169, no. 15 (2009): 1364–71.
1. Rauch, P. In conversation with author. February 25, 2010.